Digital tool aims to ease end-of-life planning for caregivers

NCT ID NCT07134881

Recruiting now Knowledge-focused Sponsor: National University of Singapore Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study tests whether a digital website called Careverse can help caregivers of people with serious illnesses engage more in advance care planning. About 200 caregivers will be randomly assigned to use the website or receive usual care. Researchers will measure how involved caregivers feel in planning through questionnaires over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Careverse (a digital psychoeducational website)
What this could lead to: If it works, this could point toward a simple digital tool that helps caregivers feel more prepared and confident in making medical decisions for their loved ones.
What could go wrong: This is a small, early-stage trial focused on measuring engagement, not health outcomes. The website may not improve planning or may be too complex for some users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCE CARE PLANNING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain neoplasm chronic kidney disease end stage renal failure glioma intracerebral hemorrhage kidney failure metastatic malignant neoplasm in the brain social phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCE CARE PLANNING DIGITAL EDUCATION INTERVENTIONS GOALS OF CARE PALIATIVE CARE VALUES, SOCIAL

Contacts and locations

Show contact details

Locations

National University Hospital
RECRUITING

Singapore, 119074, Singapore

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.